English
Pусский
Français
Deutsch
العربية
Português
Español
简体中文

News Detail
Home / News / Industry News / How HPLC Enables Reliable Thalassemia Detection During HbA1c Analysis

How HPLC Enables Reliable Thalassemia Detection During HbA1c Analysis

Publish Time: 2026-04-14     Origin: Site

Goldsite HPLC Thalassemia and HbA1c Analysis

How HPLC Enables Reliable Thalassemia Detection During HbA1c Analysis

Ion-exchange HPLC utilizes isoelectric point differences to resolve:

  • HbA1c: Glycated HbA
  • HbA0: Non-glycated adult hemoglobin
  • HbA2: δ-chain variant, elevated in β-thalassemia trait
  • HbF: Fetal hemoglobin, often raised in β-thalassemia or hereditary persistence of fetal hemoglobin
  • Common variants: HbS, HbE, HbD, etc.

In standard “fast” HbA1c modes, subtle elevations may be overlooked. Dedicated Thalassemia Mode extends run time for higher resolution, allowing precise quantification in one seamless analysis.

Evidence from Clinical Studies

  • Incidental detection of variants and thalassemia traits occurs in 0.7% or more of routine HbA1c runs using HPLC, with careful chromatogram review preventing misreporting.
  • β-thalassemia minor can cause discordantly low HbA1c with abnormal chromatograms; HPLC flags these for further investigation (e.g., genetic testing).
  • In high-prevalence settings, combined HbA1c + HbA2/HbF reporting improves carrier screening efficiency and ensures diabetes management remains evidence-based.

NGSP and IFCC standardization ensures results are traceable to DCCT/UKPDS outcomes, while HPLC’s visual chromatogram allows laboratorians to review peaks and apply flags (e.g., variant risk alerts).

Goldsite GSH-50 & GSH-60: Triple-Mode Excellence for Integrated Diagnostics

Our NGSP/IFCC-certified HPLC analyzers are purpose-built for real-world laboratories serving diverse populations:

  • Normal Mode (60 seconds): Routine HbA1c quantification (range 2.8%–18.4%, CV ≤1.5%).
  • Variant Mode (96 seconds): Enhanced separation and on-screen alerts for common variants (HbS, HbC, HbE, etc.).
  • Thalassemia Mode (390 seconds): Simultaneous, precise measurement of HbA1c, HbA2 (linear range 1.5%–11.4%), and HbF (1.0%–16.5%) in one run.

Key Performance Benefits

  • 3 µL sample volume — suitable for adults, children, and capillary collections.
  • High correlation (r⊃2; ≥0.99) with reference methods.
  • Self-developed high-performance columns with up to 8000-test lifespan.
  • GSH-60 offers 110-sample capacity with STAT position and automatic loading.
  • Compact footprint, color touch screen, and LIS connectivity.

Clinical Takeaways and Recommendations

  1. Review Every Chromatogram: Even in Normal Mode, inspect for abnormal peaks or elevated HbA2/HbF.
  2. Population-Specific Strategy: In thalassemia-endemic regions, default to or routinely include Thalassemia Mode.
  3. Complementary Testing: When HPLC flags abnormalities, correlate with CBC (MCV/MCH), hemoglobin electrophoresis, or molecular testing.
  4. Patient Impact: Reliable results prevent misdiagnosis of diabetes and support public health efforts in thalassemia prevention.

Contact Us

Your Path to Accurate Diagnostics.

Email: export@goldsite.com.cn
Website: en.goldsite.com.cn

Know more about GSH-60 and GSH-50?

Contact Goldsite for a Virtual Demo

Goldsite Diagnostics Inc. — Since 1999, delivering precision that cares for every life, every result, every community.

Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap